Phibro Animal Health Stock Profit Margin
PAHC Stock | USD 16.76 0.41 2.51% |
Phibro Animal Health fundamentals help investors to digest information that contributes to Phibro Animal's financial success or failures. It also enables traders to predict the movement of Phibro Stock. The fundamental analysis module provides a way to measure Phibro Animal's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Phibro Animal stock.
Last Reported | Projected for Next Year | ||
Net Profit Margin | 0.03 | 0.03 |
Phibro | Profit Margin |
Phibro Animal Health Company Profit Margin Analysis
Phibro Animal's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Phibro Animal Profit Margin | 0.02 % |
Most of Phibro Animal's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Phibro Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Phibro Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Phibro Animal is extremely important. It helps to project a fair market value of Phibro Stock properly, considering its historical fundamentals such as Profit Margin. Since Phibro Animal's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Phibro Animal's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Phibro Animal's interrelated accounts and indicators.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Phibro Pretax Profit Margin
Pretax Profit Margin |
|
Based on the latest financial disclosure, Phibro Animal Health has a Profit Margin of 0.0151%. This is 100.13% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The profit margin for all United States stocks is 101.19% lower than that of the firm.
Phibro Profit Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Phibro Animal's direct or indirect competition against its Profit Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Phibro Animal could also be used in its relative valuation, which is a method of valuing Phibro Animal by comparing valuation metrics of similar companies.Phibro Animal is currently under evaluation in profit margin category among related companies.
Phibro Fundamentals
Return On Equity | 0.0549 | ||||
Return On Asset | 0.0372 | ||||
Profit Margin | 0.02 % | ||||
Operating Margin | 0.06 % | ||||
Current Valuation | 1.07 B | ||||
Shares Outstanding | 20.34 M | ||||
Shares Owned By Insiders | 0.62 % | ||||
Shares Owned By Institutions | 99.38 % | ||||
Number Of Shares Shorted | 626.54 K | ||||
Price To Earning | 11.39 X | ||||
Price To Book | 1.96 X | ||||
Price To Sales | 0.54 X | ||||
Revenue | 977.89 M | ||||
Gross Profit | 298.24 M | ||||
EBITDA | 108.49 M | ||||
Net Income | 32.61 M | ||||
Cash And Equivalents | 98.67 M | ||||
Cash Per Share | 2.44 X | ||||
Total Debt | 509.97 M | ||||
Debt To Equity | 1.79 % | ||||
Current Ratio | 2.97 X | ||||
Book Value Per Share | 6.69 X | ||||
Cash Flow From Operations | 13.31 M | ||||
Short Ratio | 4.82 X | ||||
Earnings Per Share | 0.37 X | ||||
Price To Earnings To Growth | 1.66 X | ||||
Target Price | 10.75 | ||||
Number Of Employees | 1.92 K | ||||
Beta | 0.74 | ||||
Market Capitalization | 662.23 M | ||||
Total Asset | 971.4 M | ||||
Retained Earnings | 260.91 M | ||||
Working Capital | 409.72 M | ||||
Current Asset | 342.83 M | ||||
Current Liabilities | 108.78 M | ||||
Annual Yield | 0.03 % | ||||
Five Year Return | 1.85 % | ||||
Net Asset | 971.4 M | ||||
Last Dividend Paid | 0.48 |
About Phibro Animal Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Phibro Animal Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Phibro Animal using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Phibro Animal Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Phibro Animal in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Phibro Animal's short interest history, or implied volatility extrapolated from Phibro Animal options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Phibro Animal Health using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Phibro Animal Piotroski F Score and Phibro Animal Altman Z Score analysis. Note that the Phibro Animal Health information on this page should be used as a complementary analysis to other Phibro Animal's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Complementary Tools for Phibro Stock analysis
When running Phibro Animal's price analysis, check to measure Phibro Animal's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Phibro Animal is operating at the current time. Most of Phibro Animal's value examination focuses on studying past and present price action to predict the probability of Phibro Animal's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Phibro Animal's price. Additionally, you may evaluate how the addition of Phibro Animal to your portfolios can decrease your overall portfolio volatility.
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Transaction History View history of all your transactions and understand their impact on performance | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Phibro Animal's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Phibro Animal. If investors know Phibro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Phibro Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.83) | Dividend Share 0.48 | Earnings Share 0.37 | Revenue Per Share 24.245 | Quarterly Revenue Growth 0.022 |
The market value of Phibro Animal Health is measured differently than its book value, which is the value of Phibro that is recorded on the company's balance sheet. Investors also form their own opinion of Phibro Animal's value that differs from its market value or its book value, called intrinsic value, which is Phibro Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Phibro Animal's market value can be influenced by many factors that don't directly affect Phibro Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Phibro Animal's value and its price as these two are different measures arrived at by different means. Investors typically determine if Phibro Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Phibro Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.